Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3

Blood

Volumn 97, Issue 5, 2001, Pages 1435-1441

  Tomasson, Michael H ^a   Williams, Ifor R ^b   Li, Shaoguang ^b   Kutok, Jeffrey ^b   Cain, Danielle ^b   Gillessen, Silke ^b   Dranoff, Glenn ^b   Van Etten, Richard A ^b   Gilliland, D Gary ^b  

^a Division of Oncology   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYBRID PROTEIN; INTERLEUKIN 3; NEUROTROPHIN 3 RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN TYROSINE KINASE;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; LEUKEMIA CELL; MOUSE; MYELOPOIESIS; MYELOPROLIFERATIVE DISORDER; NONHUMAN; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0035282956     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.5.1435     Document Type: Article

References (55)

1. Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism
2. Neoplastic transformation of mast cells by Abelson-MuLV: Abrogation of IL-3 dependence by a non-autocrine mechanism
3. Lack of evidence for abnormal autocrine or paracrine mechanisms underlying the uncontrolled proliferation of primitive chronic myeloid leukemia progenitor cells
4. The Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to-S phase transition in hematopoietic cells
5. The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway
6. The survival function of the Bcr-Abl oncogene is mediated by Bad-dependent and -independent pathways: Roles for phosphatidyl-inositol 3-kinase and Raf
7. Bcr-Abl kinase promotes cell cycle entry of primary myeloid CML cells in the absence of growth factors
8. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients
9. Stimulation by leukaemic sera of colony formation in solid agar cultures by proliferation of mouse bone marrow cells
10. Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia
11. Colony-stimulating factor and inhibitor levels in acute granulocytic leukemia
12. Production of colony-stimulating factor by leukemic leukocytes
13. Constitutive expression of hematopoietic growth factor genes by acute myeloblastic leukemia cells
14. Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineage
15. Expression of bcr-abl abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism
16. Constitutive and induced expression of growth factors in normal and chronic phase chronic myelogenous leukemia Ph1 bone marrow stroma
17. Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia
18. Culture of human leukemia cells
19. Improved growth of in vitro colonies in human acute leukemia with the feeding culture method
20. Behavior of human leukemic progenitor populations in long-term marrow culture
21. Growth factor-mediated terminal differentiation of chronic myeloid leukemia
22. Granulocyte-macrophage colony-stimulating factor is an endogenous regulator of cell proliferation in juvenile chronic myelogenous leukemia
23. Interleukin-6 and granulocyte-macrophage colony-stimulating factor are candidate growth factors for chronic myelomonocytic leukemia cells
24. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia
25. Nf1 and Gmcsf interact in myeloid leukemogenesis
26. Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line
27. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein
28. bcr-abl oncogene renders myeloid cell line factor independent: Potential autocrine mechanism in chronic myeloid leukemia
29. The BCR-ABL oncogene requires both kinase activity and src-homology 2 domain to induce cytokine secretion
30. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: Studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181)
31. Effects of recombinant GM-CSF on the blast cells of acute myeloblastic leukemia
32. Bone marrow colony-stimulating activity of serum from mice with viral-induced leukemia
33. Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: A novel model for chronic myelogenous leukemia
34. Autostimulatory mechanisms in myeloid leukemogenesis
35. Activation of multiple hemopoietic growth factor genes in Abelson virus-transformed myeloid cells
36. Autocrine production of pre-B-cell stimulating activity by a variety of transformed murine pre-B-cell lines
37. The role of interleukin-1 and granulocyte-macrophage colony-stimulating factor in the paracrine stimulation of an in vivo-derived murine myeloid leukemia
38. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome
39. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes
40. TEL/PDGFR induces a fatal myeloproliferative disease in mice that requires tyrosines 579/581 of PDGFbR
41. Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia
42. Generation of an autocrine leukaemia using a retroviral expression vector carrying the interleukin-3 gene
43. A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony stimulating factor
44. Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage
45. Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus
46. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice
47. Interruption of autocrine and paracrine growth-stimulatory mechanisms: A new therapeutic strategy for chronic myelogenous leukemia
48. kat: A high-efficiency retroviral transduction system for primary human T lymphocytes
49. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity
50. TEL/PDGFβR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor
51. Interleukin 3 and granulocyte-maorophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL
52. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis
53. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology
54. Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice
55. Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2